Literature DB >> 17889808

Gastroesophageal reflux disease in pregnancy.

Raja Affendi Raja Ali1, Laurence J Egan.   

Abstract

Gastroesophageal reflux disease during pregnancy is common. Altered structure and function of the normal physiological barriers to reflux of gastric contents into the oesophagus explain the high incidence of this problem in pregnant women. For the majority of patients, life-style modifications are helpful, but are not sufficient to control symptoms and medication is required. The optimum management of reflux in pregnant patients requires special attention and expertise, since the safety of the mother, foetus and neonate remain the primary focus. Gastroenterologists and obstetricians should work together to optimise treatment. Typically, one utilises a step-up program that starts with life-style modifications and antacids. If those methods fail, histamine-2 receptor antagonists and proton pump inhibitors are tried. Rarely, promotility agents are used. Initiation of these medications must be undertaken after a careful discussion of risks and benefits with patients. In patients without a prior history of reflux, symptoms usually abate after delivery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889808     DOI: 10.1016/j.bpg.2007.05.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  23 in total

1.  The safety of histamine 2 (H2) blockers in pregnancy: a meta-analysis.

Authors:  Simerpal Kaur Gill; Lisa O'Brien; Gideon Koren
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

2.  Treatment of heartburn and acid reflux associated with nausea and vomiting during pregnancy.

Authors:  Ruth Law; Caroline Maltepe; Pina Bozzo; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2010-02       Impact factor: 3.275

Review 3.  Anatomical and physiological alterations of pregnancy.

Authors:  Jamil M Kazma; John van den Anker; Karel Allegaert; André Dallmann; Homa K Ahmadzia
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-02-06       Impact factor: 2.745

4.  In vitro fertilization-induced pregnancies predispose to gastroesophageal reflux disease.

Authors:  Ilker Turan; Gul Kitapcioglu; Ege Tavmergen Goker; Gulnaz Sahin; Serhat Bor
Journal:  United European Gastroenterol J       Date:  2015-07-24       Impact factor: 4.623

Review 5.  Are proton pump inhibitors safe during pregnancy and lactation? Evidence to date.

Authors:  Raj Majithia; David A Johnson
Journal:  Drugs       Date:  2012-01-22       Impact factor: 9.546

6.  Heartburn and regurgitation in pregnancy: the effect of fat ingestion.

Authors:  Valesca Dall'Alba; Fernando Fornari; Cláudio Krahe; Sidia Maria Callegari-Jacques; Sérgio Gabriel Silva de Barros
Journal:  Dig Dis Sci       Date:  2009-08-19       Impact factor: 3.199

7.  The effect of heartburn and acid reflux on the severity of nausea and vomiting of pregnancy.

Authors:  Simerpal Kaur Gill; Caroline Maltepe; Gideon Koren
Journal:  Can J Gastroenterol       Date:  2009-04       Impact factor: 3.522

8.  Quantitative determination of famotidine in human maternal plasma, umbilical cord plasma and urine using high-performance liquid chromatography-mass spectrometry.

Authors:  Xiaoming Wang; Erik Rytting; Doaa R Abdelrahman; Tatiana N Nanovskaya; Gary D V Hankins; Mahmoud S Ahmed
Journal:  Biomed Chromatogr       Date:  2013-02-12       Impact factor: 1.902

Review 9.  Basic obstetric pharmacology.

Authors:  Yang Zhao; Mary F Hebert; Raman Venkataramanan
Journal:  Semin Perinatol       Date:  2014-10-01       Impact factor: 3.300

10.  The effect of Acid-reducing pharmacotherapy on the severity of nausea and vomiting of pregnancy.

Authors:  Simerpal Kaur Gill; Caroline Maltepe; Katayoon Mastali; Gideon Koren
Journal:  Obstet Gynecol Int       Date:  2009-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.